Subjects of Study in Cell and Chromatin Reprogramming:
1. Active gene: A DNA sequence undergoing transcription to new RNA molecules.
2. Program: The pattern of active genes within a cell at a certain time and place.
3. Reprogramming: The molecular action that changes the program of a cell.
4. Telophase Reprogramming: Post-mitotic reprogramming in late telophase.
5. Interphase Reprogramming: Reprogramming during the G0, S, or G1 phases.
6. Lineage: The program sequence that results in a differentiated cell.
7. Differentiated cell: A cell with a constricted program and a specialized function.
8. Stem Cell: A cell that self-replicates indefinitely.
9. Blastula: Determination phase of organ lineages.
10. Embryo: Early organ development.
11. Fetus: Intermediate organ development.
12. Infant: Late organ development.
13. Neoplasm: Re-expression of harmful embryonic DNA sequences.
14. Regeneration: Re-expression of useful embryonic DNA sequences.
15. Types of Reprogramming:
a. Telophase Reprogramming: Endogenous activator RNA exchange.
b. Interphase Reprogramming: Exogenous activator RNA exchange.
c. DNA mutation: Covalent change in a DNA sequence.
d. Epigenetic modification: Covalent change without a DNA sequence change.
e. Viral integration: Insertion or apposition of viral DNA sequence into DNA.
f. Retrotransposon: Partial insertion or apposition of viral DNA or RNA.
g. Signal Reprogramming: Change in a program by change in signal intensity.
h. Nuclear Transplantation: Change in a program by change of the nucleus.
i. Oocyte Effect on
Nucleus: Isolated nucleus incubation with oocyte.
Return to: "Activator RNA Exchange during Interphase Chromatin Reprogramming".
Summary of: "Activator RNA Exchange during Interphase Chromatin Reprogramming".
Return to: "RNA-Induced Chromatin Remodeling and DNA Melting during Selective Gene Transcription".
Further Topics in: Euchromatin, active DNA, and RNA ribo-regulators:
Links to
Euchromatin Activator RNA Reviews:
Links to
Euchromatin Activator RNA Research:
Links to Ultrastructural
Probes of DNase I-Sensitive Sites:
Links to
RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma
Immuno-Pathology:
Links to Activated
T-Lymphocyte Immunotherapy:
Links to Medical
Systems Biology:
"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA".
For Further Information and Feedback:
E-mail: frenster@euchromatin.net